KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased Short-Term Debt issuances

West Pharmaceutical Services (WST) Shares Issued (2016 - 2026)

West Pharmaceutical Services has reported Shares Issued over the past 18 years, most recently at $5.5 million for Q1 2026.

Quarterly Shares Issued rose 189.47% to $5.5 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $14.9 million through Mar 2026, down 41.34% year-over-year, with the annual reading at $11.3 million for FY2025, 55.69% down from the prior year.
Shares Issued was $5.5 million for Q1 2026 at West Pharmaceutical Services, up from $3.1 million in the prior quarter.
Over five years, Shares Issued peaked at $22.2 million in Q2 2023 and troughed at -$35.5 million in Q4 2023.
The 5-year median for Shares Issued is $2.0 million (2022), against an average of $3.3 million.
Peak annual rise in Shares Issued hit 957.14% in 2023, while the deepest fall reached 3058.33% in 2023.
Tracing WST's Shares Issued over 5 years: stood at $1.2 million in 2022, then tumbled by 3058.33% to -$35.5 million in 2023, then soared by 104.23% to $1.5 million in 2024, then skyrocketed by 106.67% to $3.1 million in 2025, then surged by 77.42% to $5.5 million in 2026.
According to Business Quant data, Shares Issued over the past three periods came in at $5.5 million, $3.1 million, and $2.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.